Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Gerresheimer    GXI   DE000A0LD6E6

GERRESHEIMER (GXI)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Gerresheimer at MakeUp in Paris: Glass for unmistakable cosmetic products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/14/2018 | 03:03pm CEST

Gerresheimer has earned itself an excellent reputation in the world of fragrances and beauty products with its exquisite bottles, jars, and pots as well as its advice and comprehensive service.

The company has highly specialized production facilities in two locations that supply some big names in the cosmetic industry: one in Momignies, Belgium, and the other in the German city of Tettau. Both plants boast state-of-the-art production technology and outstanding specialists in designing and engineering complex shapes. The two sites also have departments dedicated to adding the final touches and embellishments to the products.

With its innovations for the packaging market, the Gerresheimer Group is a key partner for the international perfume, cosmetics, and body care industries and enjoys a strong position on the prestige and mass market.

More information

Gerresheimer Primary Packaging Glass Cosmetics

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The company's comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Disclaimer

Gerresheimer AG published this content on 14 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 14 June 2018 13:02:01 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GERRESHEIMER
07/12GERRESHEIMER : Slide show results
CO
07/11GERRESHEIMER : extends business model and increases growth forecast
PU
07/11GERRESHEIMER : acquires Sensile Medical / irrespective of that, increased growth..
EQ
07/11GERRESHEIMER : Acquisition
CO
07/09GERRESHEIMER AG : half-yearly earnings release
06/30GERRESHEIMER : Half-year report
CO
06/28GERRESHEIMER AG : Preliminary announcement of the publication of financial repor..
EQ
06/25GERRESHEIMER : an Innovative Learning Location
PU
06/19GERRESHEIMER : wows at CPhI China with innovative packaging solutions
PU
06/14GERRESHEIMER AT MAKEUP IN PARIS : Glass for unmistakable cosmetic products
PU
More news
News from SeekingAlpha
04/13Gerresheimer AG ADR 2018 Q1 - Results - Earnings Call Slides 
02/23Gerresheimer AG ADR 2017 Q4 - Results - Earnings Call Slides 
2017Gerresheimer AG ADR 2017 Q3 - Results - Earnings Call Slides 
2015Corning buying German pharma glass tubing business for $219m 
Financials (€)
Sales 2018 1 360 M
EBIT 2018 181 M
Net income 2018 125 M
Debt 2018 728 M
Yield 2018 1,58%
P/E ratio 2018 18,63
P/E ratio 2019 20,97
EV / Sales 2018 2,27x
EV / Sales 2019 2,14x
Capitalization 2 361 M
Chart GERRESHEIMER
Duration : Period :
Gerresheimer Technical Analysis Chart | GXI | DE000A0LD6E6 | 4-Traders
Technical analysis trends GERRESHEIMER
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 72,6 €
Spread / Average Target -3,5%
EPS Revisions
Managers
NameTitle
Axel Herberg Chairman-Supervisory Board
Rainer Beaujean Chief Financial Officer
Theodor Stuth Independent Member-Supervisory Board
Udo J. Vetter Independent Member-Supervisory Board
Francesco Grioli Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
GERRESHEIMER8.80%2 759
MEDTRONIC PLC9.42%119 437
BAXTER INTERNATIONAL15.69%40 217
ALIGN TECHNOLOGY63.58%29 130
ZIMMER BIOMET HOLDINGS-4.79%23 354
HOYA CORPORATION10.59%21 544